Table 4.
Clinicopathologic characteristics of patients with cancer cell positive lymph nodes.
| No. | pTMN/ cStage | Lymphatic flow | Fluorescence region | LN metastasis | Tumor location/ operation |
|---|---|---|---|---|---|
| 1 | T2, N1, M0/ IIIa | + | ICA | Paracolic LNs | C/ lap-C |
| 2 | T3, N1, M0/ IIIa | + | ICA | Paracolic LNs | C/ lap-C |
| 3 | T3, N2, M0/ IIIa | + | acRtV | Central LNs of RCA | A/ lap-Rt |
| 4 | T3, N1, M0/ IIIa | + | acRtV | Paracolic LNs | A/ lap-Rt |
| 5 | T4a, N1, M0/ IIIa | + | RCA | Paracolic LNs | A/ lap-Rt |
| 6 | T3, N1, M0/ IIIa | + | MCA Rt | Intermediate LNs of MCA | A/ lap-Rt |
| 7 | T1b, N1, M0/ IIIa | + | MCA Rt | Paracolic LNs | T/ lap-T |
| 8 | T3, N1, M0/ IIIa | + | MCA Lt | Paracolic LNs | T/ lap-Lt |
| 9 | T4a, N1, M1/ IV | + | MCA Lt | Paracolic LNs | T/ lap-Lt |
| 10 | T3, N1, M0/ IIIa | + | LCA | Paracolic LNs | T/ lap-Lt |
| 11 | T4b, N1, M1/ IV | + | IMA | Paracolic LNs | S/ lap-S |
| 12 | T3, N2, M0/ IIIb | − | – | Paracolic LNs | C/ lap-C |
| 13 | T3, N1, M0/ IIIa | − | – | Paracolic LNs | A/ lap-Rt |
| 14 | T3, N1, M0/ IIIa | − | – | Paracolic LNs | S/ lap-S |
| 15 | T4a, N2, M1/ IV | − | – | Paracolic LNs, intermediate LNs of IMA | S/ lap-S |
| 16 | T4a, N3, M1/ IV | − | – | Paracolic LNs | S/ lap-S |
| 17 | T4a, N2, M1/ IV | − | – | Paracolic LNs | S/ lap-Hartmann |
C cecal cancer, A ascending colon cancer, T transverse colon cancer, D descending colon cancer, S sigmoid colon cancer, lap-C laparoscopic ileocecal resection, lap-Rt laparoscopic right hemicolectomy, lap-T laparoscopic transverse colon resection, lap-Lt laparoscopic left hemicolectomy, lap-S laparoscopic sigmoid colon resection, RCA right colic artery, MCA middle colic artery, IMA inferior mesenteric artery.